Criminalised, Stigmatised, and Underprovided: Why Germany’s Abortion Law Fails both Patients and Providers

By Amelie Kolandt, Susanne Michl & Mirjam Faissner In Germany, access to abortion remains legally restricted and structurally constrained. Our recent qualitative study “Understanding structural barriers to abortion care under the counselling regulation in Germany”, published in BMJ Sexual and Reproductive Health, highlights how criminalisation, stigma, and a lack of training undermine equitable, patient-centred abortion […]

Read More…

On being left alone, finally

By Ezio Di Nucci Imagine being a woman living under the patriarchy for 45 to 50 years. Then, slowly but surely, men finally begin to leave you alone. Wouldn’t that be liberating?   Reclaiming menopause as the long-awaited (genotypically and phenotypically) women’s liberation has been in high fashion of late, so I was surprised when one of […]

Read More…

Recommending Privately Developed FemTech in Healthcare Part 2: Understanding Healthcare Professionals’ Responsibilities

By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz In the previous blog, we introduced the issues associated with healthcare professionals (HCPs) recommending privately-developed FemTech apps. In this second blog, we turn our attention to regulatory considerations associated with this practice. There are two distinct questions which could be asked here: (1) whether HCPs should recommend […]

Read More…

Recommending Privately-Developed FemTech in Healthcare Part 1: Promises and Pitfalls

By Anna Nelson, Maria Tzanou and Tsachi Keren-Paz   Introduction  FemTech refers to apps and wearable devices (eg. smart breast pumps and bluetooth-enabled fertility monitors) purporting to empower women and non-binary users to manage their sexual, gynaecological and reproductive health. During their recent review of the data practices of period and fertility tracking apps, the […]

Read More…

Creating a consolidated EMAH (Early Medical Abortion at Home) medication pack: What has the impact been?

By Nathan Burley   Background  Up to seven medicines are provided for an early medical abortion, similar to the amount supplied after a heart attack. Abortifacients, analgesia, an anti-emetic, contraception and an antibiotic could be supplied, with each attendance resulting in at least four packs being given. Clinics providing this service may store a variety […]

Read More…

Application of a novel abortion care quality measurement tool (ACQTool) in Bangladesh

By Laura E Jacobson, Sarah E. Baum, Erin Pearson, Rezwana Chowdhury, Nirali M. Chakraborty, Julia M. Goodman, Caitlin Gerdts, & Blair G. Darney Measuring and improving quality of care is an essential part of ensuring safe and effective health services; however, until recently measuring the quality of abortion care has been hampered by a lack of shared definitions […]

Read More…